209 related articles for article (PubMed ID: 19883086)
1. Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities.
Srinivasan B; Johnson TE; Lad R; Xing C
J Med Chem; 2009 Nov; 52(22):7228-35. PubMed ID: 19883086
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxicity evaluation of biaryl-based chalcones and their potential in TNFα-induced nuclear factor-κB activation inhibition.
Zuo Y; Yu Y; Wang S; Shao W; Zhou B; Lin L; Luo Z; Huang R; Du J; Bu X
Eur J Med Chem; 2012 Apr; 50():393-404. PubMed ID: 22386368
[TBL] [Abstract][Full Text] [Related]
3. Anti-proliferative effect of chalcone derivatives through inactivation of NF-κB in human cancer cells.
Venkateswararao E; Sharma VK; Yun J; Kim Y; Jung SH
Bioorg Med Chem; 2014 Jul; 22(13):3386-92. PubMed ID: 24835787
[TBL] [Abstract][Full Text] [Related]
4. A SAR study on a series of synthetic lipophilic chalcones as inhibitor of transcription factor NF-κB.
Venkateswararao E; Sharma VK; Lee KC; Sharma N; Park SH; Kim Y; Jung SH
Eur J Med Chem; 2012 Aug; 54():379-86. PubMed ID: 22677029
[TBL] [Abstract][Full Text] [Related]
5. Natural chalcones as dual inhibitors of HDACs and NF-κB.
Orlikova B; Schnekenburger M; Zloh M; Golais F; Diederich M; Tasdemir D
Oncol Rep; 2012 Sep; 28(3):797-805. PubMed ID: 22710558
[TBL] [Abstract][Full Text] [Related]
6. Novel dual-targeting anti-proliferative dihydrotriazine-chalcone derivatives display suppression of cancer cell invasion and inflammation by inhibiting the NF-κB signaling pathway.
Gan FF; Zhang R; Ng HL; Karuppasamy M; Seah W; Yeap WH; Ong SM; Hadadi E; Wong SC; Chui WK; Chew EH
Food Chem Toxicol; 2018 Jun; 116(Pt B):238-248. PubMed ID: 29630947
[TBL] [Abstract][Full Text] [Related]
7. Bis-chalcone analogues as potent NO production inhibitors and as cytotoxic agents.
Vijaya Bhaskar Reddy M; Shen YC; Ohkoshi E; Bastow KF; Qian K; Lee KH; Wu TS
Eur J Med Chem; 2012 Jan; 47(1):97-103. PubMed ID: 22115618
[TBL] [Abstract][Full Text] [Related]
8. Design and Discovery of Some Novel Chalcones as Antioxidant and Anti-Inflammatory Agents via Attenuating NF-κB.
Chu J; Guo CL
Arch Pharm (Weinheim); 2016 Jan; 349(1):63-70. PubMed ID: 26660296
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of lantadene analogs with marked in vitro inhibition of lung adenocarcinoma and TNF-α induced nuclear factor-kappa B (NF-κB) activation.
Monika ; Sharma A; Suthar SK; Aggarwal V; Lee HB; Sharma M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3814-8. PubMed ID: 25027934
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mitogen activated protein kinases increases the sensitivity of A549 lung cancer cells to the cytotoxicity induced by a kava chalcone analog.
Warmka JK; Solberg EL; Zeliadt NA; Srinivasan B; Charlson AT; Xing C; Wattenberg EV
Biochem Biophys Res Commun; 2012 Aug; 424(3):488-92. PubMed ID: 22771807
[TBL] [Abstract][Full Text] [Related]
11. Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue.
Pandey MK; Sandur SK; Sung B; Sethi G; Kunnumakkara AB; Aggarwal BB
J Biol Chem; 2007 Jun; 282(24):17340-50. PubMed ID: 17439942
[TBL] [Abstract][Full Text] [Related]
12. The aromatic ketone 4'-hydroxychalcone inhibits TNFα-induced NF-κB activation via proteasome inhibition.
Orlikova B; Tasdemir D; Golais F; Dicato M; Diederich M
Biochem Pharmacol; 2011 Sep; 82(6):620-31. PubMed ID: 21703248
[TBL] [Abstract][Full Text] [Related]
13. Chalcone Derivatives: Role in Anticancer Therapy.
Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.
Olivera A; Moore TW; Hu F; Brown AP; Sun A; Liotta DC; Snyder JP; Yoon Y; Shim H; Marcus AI; Miller AH; Pace TW
Int Immunopharmacol; 2012 Feb; 12(2):368-77. PubMed ID: 22197802
[TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice.
Yang F; Li J; Zhu J; Wang D; Chen S; Bai X
Eur J Pharmacol; 2015 May; 754():105-14. PubMed ID: 25720342
[TBL] [Abstract][Full Text] [Related]
16. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of chalcone analogues incorporate α,β-Unsaturated ketone functionality as anti-lung cancer agents via evoking ROS to induce pyroptosis.
Zhu M; Wang J; Xie J; Chen L; Wei X; Jiang X; Bao M; Qiu Y; Chen Q; Li W; Jiang C; Zhou X; Jiang L; Qiu P; Wu J
Eur J Med Chem; 2018 Sep; 157():1395-1405. PubMed ID: 30196062
[TBL] [Abstract][Full Text] [Related]
18. 2',4-Dihydroxy-3',4',6'-trimethoxychalcone from Chromolaena odorata possesses anti-inflammatory effects via inhibition of NF-κB and p38 MAPK in lipopolysaccharide-activated RAW 264.7 macrophages.
Dhar R; Kimseng R; Chokchaisiri R; Hiransai P; Utaipan T; Suksamrarn A; Chunglok W
Immunopharmacol Immunotoxicol; 2018 Feb; 40(1):43-51. PubMed ID: 29199487
[TBL] [Abstract][Full Text] [Related]
19. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
20. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.
Lee JH; Jung HS; Giang PM; Jin X; Lee S; Son PT; Lee D; Hong YS; Lee K; Lee JJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):271-8. PubMed ID: 16183703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
